조선대학교 자연과학·공공보건안전대학 의생명과학과

펩타이드 의학 실험실

1999년

1.	Park Y, Kim H H, and Cheong H, The expression of petunia flavonoid 3′ and 3′ 5′ hydroxylase genes in potatoes (Solanum tuberosum cv. Jopung). Biotechnology and Bioprocess Engineering, 1999. 4(4): p. 305-308.

2001년

2.	Park Y and Hahm K S, High Value-Added Peptide/Protein Materials. Journal of the Korean Medical Association, 2001. 44(7): p. 727-731.

3.	Lee D G, Kim D H, Park Y, Kim H K, Kim H N, Shin Y K, Choi C H, and Hahm K S, Fungicidal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Candida albicans. Biochem Biophys Res Commun, 2001. 282(2): p. 570-4.

4.	Park Y and Cheong H, The effect of the recombinant human interleukin-2 Gene in potato (Solanum tuberosum cv. superior). Journal of Plant Biology, 2001. 44(4): p. 193-198.

2002년

5.	Lee D G, Park Y, Kim H N, Kim H K, Kim P I, Choi B H, and Hahm K S, Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans. Biochem Biophys Res Commun, 2002. 291(4): p. 1006-13.

6.	Kim H K, Lee D G, Park Y, Kim H N, Choi B H, Choi C-H, and Hahm K-S, Antibacterial activities of peptides designed as hybrids of antimicrobial peptides. Biotechnology letters, 2002. 24(5): p. 347-353.

7.	Lee D G, Kim P I, Park Y, Woo E R, Choi J S, Choi C H, and Hahm K S, Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem Biophys Res Commun, 2002. 293(1): p. 231-8.

8.	Park Y and Cheong H, Expression and production of recombinant human interleukin-2 in potato plants. Protein Expr Purif, 2002. 25(1): p. 160-5.

9.	Park Y, Lee D G, Kim H N, Kim H K, Woo E-R, Choi C-H, and Hahm K-S, Importance of the length of the N-and C-terminal regions of Helicobacter pylori ribosomal protein L1 (RPL1) on its antimicrobial activity. Biotechnology letters, 2002. 24(14): p. 1209-1215.

10.	Lee D G, Kim P I, Park Y, Park S C, Woo E R, and Hahm K S, Antifungal mechanism of SMAP-29 (1-18) isolated from sheep myeloid mRNA against Trichosporon beigelii. Biochem Biophys Res Commun, 2002. 295(3): p. 591-6.

11.	Lee D G, Kim H N, Park Y, Kim H K, Choi B H, Choi C H, and Hahm K S, Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Biochim Biophys Acta, 2002. 1598(1-2): p. 185-94.

12.	Lee D G, Kim P I, Park Y, Jang S H, Park S C, Woo E R, and Hahm K S, HP (2-20) derived from the amino terminal region of helicobacterpylori ribosomal protein L1 exerts its antifungal effects by damaging the plasma membranes of Candida albicans. J Pept Sci, 2002. 8(8): p. 453-60.

13.	Lee D-G, Chang Y-S, Park Y-K, Hahm K-S, and Woo E-R, Antimicrobial effects of ocotillone isolated from stem bark of Ailanthus altisshima. Journal of microbiology and biotechnology, 2002. 12(5): p. 854-857.

14.	Woo E R, Lee D G, Chang Y S, Park Y, and Hahm K S, Virus-cell fusion inhibitory activity of novel analogue peptides based on the HP (2-20) derived from N-terminus of Helicobacter pylori Ribosomal Protein L1. Protein Pept Lett, 2002. 9(6): p. 477-86.

15.	Lee D G, Park Y, Kim P I, Jeong H G, Woo E R, and Hahm K S, Influence on the plasma membrane of Candida albicans by HP (2-9)-magainin 2 (1-12) hybrid peptide. Biochem Biophys Res Commun, 2002. 297(4): p. 885-9.

16.	Kim H K, Park Y, Kim H N, Choi B H, Jeong H G, Lee D G, and Hahm K-S, Antimicrobial mechanism of β-glycyrrhetinic acid isolated from licorice, Glycyrrhiza glabra. Biotechnology letters, 2002. 24(22): p. 1899-1902.

2003년

17.	Park Y, Lee D G, Jang S H, Woo E R, Jeong H G, Choi C H, and Hahm K S, A Leu-Lys-rich antimicrobial peptide: activity and mechanism. Biochim Biophys Acta, 2003. 1645(2): p. 172-82.

18.	Lee D G, Kim H K, Kim S A, Park Y, Park S C, Jang S H, and Hahm K S, Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem Biophys Res Commun, 2003. 305(2): p. 305-10.

19.	Piao M S, Kim M R, Lee D G, Park Y, Hahm K S, Moon Y H, and Woo E R, Antioxidative constituents from Buddleia officinalis. Arch Pharm Res, 2003. 26(6): p. 453-7.

20.	Park Y, Lee D G, and Hahm K S, Antibiotic activity of Leu-Lys rich model peptides. Biotechnol Lett, 2003. 25(16): p. 1305-10.

21.	Lee D G, Kim H K, Park Y, Park S C, Woo E R, Jeong H G, and Hahm K S, Gram-positive bacteria specific properties of silybin derived from Silybum marianum. Arch Pharm Res, 2003. 26(8): p. 597-600.

2004년

22.	Jang S H, Park Y, Park S C, Kim P I, Lee D G, and Hahm K S, Antinematodal activity and the mechanism of the antimicrobial peptide, HP (2-20), against Caenorhabditis elegans. Biotechnol Lett, 2004. 26(4): p. 287-91.

23.	Park Y, Lee D G, and Hahm K S, HP(2-9)-magainin 2(1-12), a synthetic hybrid peptide, exerts its antifungal effect on Candida albicans by damaging the plasma membrane. J Pept Sci, 2004. 10(4): p. 204-9.

24.	Park Y, Kim H N, Park S N, Jang S-H, Choi C-H, Lim H-T, and Hahm K-S, Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP (2-9)-ME (1-12). Biotechnology letters, 2004. 26(6): p. 493-498.

25.	Lee D G, Park Y, Jin I, Hahm K S, Lee H H, Moon Y H, and Woo E R, Structure-antiviral activity relationships of cecropin A-magainin 2 hybrid peptide and its analogues. J Pept Sci, 2004. 10(5): p. 298-303.

26.	Park Y, Jang S H, Lee D G, and Hahm K S, Antinematodal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Caenorhabditis elegans. J Pept Sci, 2004. 10(5): p. 304-11.

27.	Lee D G, Park Y, Kim M R, Jung H J, Seu Y B, Hahm K S, and Woo E R, Anti-fungal effects of phenolic amides isolated from the root bark of Lycium chinense. Biotechnol Lett, 2004. 26(14): p. 1125-30.

28.	Park Y, Kim H J, and Hahm K S, Antibacterial synergism of novel antibiotic peptides with chloramphenicol. Biochem Biophys Res Commun, 2004. 321(1): p. 109-15.

29.	Park Y, Park S N, Park S C, Park J Y, Park Y H, Hahm J S, and Hahm K S, Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones. Biochem Biophys Res Commun, 2004. 321(3): p. 631-7.

30.	Klotz S A, Gaur N K, Rauceo J, Lake D F, Park Y, Hahm K, and Lipke P N, Inhibition of adherence and killing of Candida albicans with a 23-Mer peptide (Fn/23) with dual antifungal properties. Antimicrobial agents and chemotherapy, 2004. 48(11): p. 4337-4341.

2005년

31.	Park Y and Hahm K S, Effects of N- and C-terminal truncation of HP (2-20) from Helicobacter pylori ribosomal protein L1 (RPL1) on its anti-microbial activity. Biotechnol Lett, 2005. 27(3): p. 193-9.

32.	Kim J Y, Park S C, Kim M H, Lim H T, Park Y, and Hahm K S, Antimicrobial activity studies on a trypsin-chymotrypsin protease inhibitor obtained from potato. Biochem Biophys Res Commun, 2005. 330(3): p. 921-7.

33.	Lee D G, Hahm K S, Park Y, Kim H Y, Lee W, Lim S C, Seo Y K, and Choi C H, Functional and structural characteristics of anticancer peptide Pep27 analogues. Cancer Cell Int, 2005. 5: p. 21.

34.	Park Y, Choi B H, Kwak J S, Kang C W, Lim H T, Cheong H S, and Hahm K S, Kunitz-type serine protease inhibitor from potato (Solanum tuberosum L. cv. Jopung). J Agric Food Chem, 2005. 53(16): p. 6491-6.

35.	Park Y and Hahm K S, Antimicrobial peptides (AMPs): peptide structure and mode of action. J Biochem Mol Biol, 2005. 38(5): p. 507-16.

36.	Song Y M, Park Y, Lim S S, Yang S T, Woo E R, Park I S, Lee J S, Kim J I, Hahm K S, Kim Y, and Shin S Y, Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry, 2005. 44(36): p. 12094-106.

37.	Lim S S, Kim Y, Park Y, Kim J I, Park I S, Hahm K S, and Shin S Y, The role of the central L- or D-Pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide. Biochem Biophys Res Commun, 2005. 334(4): p. 1329-35.

2006년

38.	Park Y, Park S N, Park S C, Shin S O, Kim J Y, Kang S J, Kim M H, Jeong C Y, and Hahm K S, Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. Biochim Biophys Acta, 2006. 1764(1): p. 24-32.

39.	Park Y, Hahm J S, and Hahm K S, Antibiotic activity of antimicrobial peptide against Pseudomonads isolated from a patient with gallstones. Protein Pept Lett, 2006. 13(1): p. 53-8.

40.	Lee K H, Lee D G, Park Y, Kang D I, Shin S Y, Hahm K S, and Kim Y, Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori. Biochem J, 2006. 394(Pt 1): p. 105-14.

41.	Tripathi G, Li H, Park J, Park Y, and Cheong H, Molecular screening and characterization of antiviral potatoes. Biotechnology and Bioprocess Engineering, 2006. 11(2): p. 89.

42.	Zhu W L, Park Y, Park I S, Park Y S, Kim Y, Hahm K S, and Shin S Y, Improvement of bacterial cell selectivity of melittin by a single Trp mutation with a peptoid residue. Protein Pept Lett, 2006. 13(7): p. 719-25.

43.	Park S C, Kim J Y, Shin S O, Jeong C Y, Kim M H, Shin S Y, Cheong G W, Park Y, and Hahm K S, Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy. Biochem Biophys Res Commun, 2006. 343(1): p. 222-8.

44.	Lim S S, Yoon S-P, Park Y, Zhu W L, Park I-S, Hahm K-S, and Shin S Y, Mechanism of antibacterial action of a synthetic peptide with an Ala-peptoid residue based on the scorpion-derived antimicrobial peptide IsCT. Biotechnology letters, 2006. 28(18): p. 1431-1437.

45.	Jung H J, Park Y, Hahm K S, and Lee D G, Biological activity of Tat (47-58) peptide on human pathogenic fungi. Biochem Biophys Res Commun, 2006. 345(1): p. 222-8.

46.	Kim M H, Park S C, Kim J Y, Lee S Y, Lim H T, Cheong H, Hahm K S, and Park Y, Purification and characterization of a heat-stable serine protease inhibitor from the tubers of new potato variety "Golden Valley". Biochem Biophys Res Commun, 2006. 346(3): p. 681-6.

47.	Zhu W L, Lan H, Park Y, Yang S T, Kim J I, Park I S, You H J, Lee J S, Park Y S, Kim Y, Hahm K S, and Shin S Y, Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide. Biochemistry, 2006. 45(43): p. 13007-17.

48.	Tripathi G R, Park J, Park Y, Hwang I, Park Y, Hahm K S, and Cheong H, Potide-G derived from potato (Solanum tuberosum L.) is active against potato virus YO (PVYO) infection. J Agric Food Chem, 2006. 54(22): p. 8437-43.

2007년

49.	Lee J R, Park S C, Kim J Y, Lee S S, Park Y, Cheong G W, Hahm K S, and Lee S Y, Molecular and functional characterization of a cyclophilin with antifungal activity from Chinese cabbage. Biochem Biophys Res Commun, 2007. 353(3): p. 672-8.

50.	Park Y, Park S C, Park H K, Shin S Y, Kim Y, and Hahm K S, Structure-activity relationship of HP (2-20) analog peptide: enhanced antimicrobial activity by N-terminal random coil region deletion. Biopolymers, 2007. 88(2): p. 199-207.

51.	Nan Y H, Park K H, Jeon Y J, Park Y, Park I S, Hahm K S, and Shin S Y, Antimicrobial and anti-inflammatory activities of a Leu/Lys-rich antimicrobial peptide with Phe-peptoid residues. Protein Pept Lett, 2007. 14(10): p. 1003-7.

52.	Park S C, Lee J R, Shin S O, Jung J H, Lee Y M, Son H, Park Y, Lee S Y, and Hahm K S, Purification and characterization of an antifungal protein, C-FKBP, from Chinese cabbage. J Agric Food Chem, 2007. 55(13): p. 5277-81.

53.	Jung H J, Park Y, Sung W S, Suh B K, Lee J, Hahm K S, and Lee D G, Fungicidal effect of pleurocidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance. Biochim Biophys Acta, 2007. 1768(6): p. 1400-5.

54.	Zhu W L, Song Y M, Park Y, Park K H, Yang S T, Kim J I, Park I S, Hahm K S, and Shin S Y, Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim Biophys Acta, 2007. 1768(6): p. 1506-17.

55.	Lee J R, Park S C, Kim M H, Jung J H, Shin M R, Lee D H, Cheon M G, Park Y, Hahm K S, and Lee S Y, Antifungal activity of rice Pex5p, a receptor for peroxisomal matrix proteins. Biochem Biophys Res Commun, 2007. 359(4): p. 941-6.

56.	Kim J Y, Lee S Y, Park S C, Shin S Y, Choi S J, Park Y, and Hahm K S, Purification and antimicrobial activity studies of the N-terminal fragment of ubiquitin from human amniotic fluid. Biochim Biophys Acta, 2007. 1774(9): p. 1221-6.

57.	Park S C, Lee J R, Shin S O, Park Y, Lee S Y, and Hahm K S, Characterization of a heat-stable protein with antimicrobial activity from Arabidopsis thaliana. Biochem Biophys Res Commun, 2007. 362(3): p. 562-7.

58.	Sung W S, Park Y, Choi C H, Hahm K S, and Lee D G, Mode of antibacterial action of a signal peptide, Pep27 from Streptococcus pneumoniae. Biochem Biophys Res Commun, 2007. 363(3): p. 806-10.

2008년

59.	Park S C, Kim M H, Hossain M A, Shin S Y, Kim Y, Stella L, Wade J D, Park Y, and Hahm K S, Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Biochim Biophys Acta, 2008. 1778(1): p. 229-41.

60.	Jin Z, Yang Y, Choi J, Shinde P, Yoon S, Hahn T-W, Lim H, Park Y, Hahm K, and Joo J, Effects of potato (Solanum tuberosum L. cv. Golden valley) protein having antimicrobial activity on the growth performance, and intestinal microflora and morphology in weanling pigs. Animal Feed Science and Technology, 2008. 140(1-2): p. 139-154.

61.	Kwon A S, Park G C, Ryu S Y, Lim D H, Lim D Y, Choi C H, Park Y, and Lim Y, Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. International journal of antimicrobial agents, 2008. 32(1): p. 68-72.

62.	Park K H, Park Y, Park I S, Hahm K S, and Shin S Y, Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides. J Pept Sci, 2008. 14(7): p. 876-82.

63.	Mereuta L, Luchian T, Park Y, and Hahm K S, Single-molecule investigation of the interactions between reconstituted planar lipid membranes and an analogue of the HP(2-20) antimicrobial peptide. Biochem Biophys Res Commun, 2008. 373(4): p. 467-72.

64.	Park Y, Kim M H, Park S C, Cheong H, Jang M K, Nah J W, and Hahm K S, Investigation of the antifungal activity and mechanism of action of LMWS-chitosan. J Microbiol Biotechnol, 2008. 18(10): p. 1729-34.

65.	Park S C, Yoo N C, Kim J Y, Park H K, Chae B J, Shin S Y, Cheong H, Park Y, and Hahm K S, Isolation and characterization of an extracellular antimicrobial protein from Aspergillus oryzae. J Agric Food Chem, 2008. 56(20): p. 9647-52.

66.	Park H K, Lim H T, Chae B J, Hahm K S, and Park Y, Influence of the N- and C-terminal regions of leu-lys rich antimicrobial peptide on antimicrobial activity. Protein Pept Lett, 2008. 15(2): p. 188-92.

2009년

67.	Jeong Y I, Seo D H, Kim D G, Choi C, Jang M K, Nah J W, and Park Y, Methotrexate-incorporated polymeric micelles composed of methoxy poly(ethylene glycol)-grafted chitosan. Macromolecular Research, 2009. 17(7): p. 538-543.

68.	Nan Y H, Park K H, Park Y, Jeon Y J, Kim Y, Park I S, Hahm K S, and Shin S Y, Investigating the effects of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti-inflammatory activity of a Trp-rich antimicrobial peptide indolicidin. FEMS Microbiol Lett, 2009. 292(1): p. 134-40.

69.	Mereuta L, Luchian T, Park Y, and Hahm K S, The role played by lipids unsaturation upon the membrane interaction of the Helicobacter pylori HP (2–20) antimicrobial peptide analogue HPA3. Journal of bioenergetics and biomembranes, 2009. 41(1): p. 79.

70.	De Zotti M, Biondi B, Formaggio F, Toniolo C, Stella L, Park Y, and Hahm K S, Trichogin GA IV: an antibacterial and protease-resistant peptide. Journal of Peptide Science, 2009. 15(9): p. 615-619.

71.	Orioni B, Bocchinfuso G, Kim J Y, Palleschi A, Grande G, Bobone S, Park Y, Kim J I, Hahm K s, and Stella L, Membrane perturbation by the antimicrobial peptide PMAP-23: A fluorescence and molecular dynamics study. Biochimica et Biophysica Acta (BBA) - Biomembranes, 2009. 1788(7): p. 1523-1533.

72.	Bocchinfuso G, Palleschi A, Orioni B, Grande G, Formaggio F, Toniolo C, Park Y, Hahm K S, and Stella L, Different mechanisms of action of antimicrobial peptides: insights from fluorescence spectroscopy experiments and molecular dynamics simulations. Journal of Peptide Science, 2009. 15(9): p. 550-558.

73.	Yoon H, Park Y, and Kim G H, Drug delivery system using electrospun nanofiber mats. Polymer Korea, 2009. 33(3): p. 219-223.

74.	Kim J Y, Park S C, Hwang I, Cheong H, Nah J W, Hahm K S, and Park Y, Protease Inhibitors from Plants with Antimicrobial Activity. International Journal of Molecular Sciences, 2009. 10(6): p. 2860-2872.

75.	Lee J, Park C, Park S C, Woo E R, Park Y, Hahm K S, and Lee D G, Cell selectivity-membrane phospholipids relationship of the antimicrobial effects shown by pleurocidin enantiomeric peptides. Journal of Peptide Science, 2009. 15(9): p. 601-606.

76.	Choi C Y, Jung H, Nam J P, Park Y, Jang M K, and Nah J W, Preparation and characterization of deoxycholic acid-conjugated low molecular weight water-soluble chitosan nanoparticles for hydrophobic antifungal agent carrier. Polymer Korea, 2009. 33(4): p. 389-395.

77.	Gopal R, Park S C, Ha K J, Cho S J, Kim S W, Song P I, Nah J W, Park Y, and Hahm K S, Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide. Journal of Peptide Science, 2009. 15(9): p. 589-594.

78.	Jin Z, Shinde P L, Yang Y X, Choi J Y, Yoon S Y, Hahn T W, Lim H T, Park Y, Hahm K S, Joo J W, and Chae B J, Use of refined potato (Solanum tuberosum L. cv. Gogu valley) protein as an alternative to antibiotics in weanling pigs. Livestock Science, 2009. 124(1): p. 26-32.

79.	Mereuta L, Luchian T, Park Y, and Hahm K S, The role played by lipids unsaturation upon the membrane interaction of the Helicobacter pylori HP(2-20) antimicrobial peptide analogue HPA3. J Bioenerg Biomembr, 2009. 41(1): p. 79-84.

80.	Park S C, Lee J R, Kim J Y, Hwang I, Nah J W, Cheong H, Park Y, and Hahm K S, Pr-1, a novel antifungal protein from pumpkin rinds. Biotechnology Letters, 2009. 32(1): p. 125.

81.	Park S C, Kim J Y, Lee J K, Hwang I, Cheong H, Nah J W, Hahm K S, and Park Y, Antifungal Mechanism of a Novel Antifungal Protein from Pumpkin Rinds against Various Fungal Pathogens. Journal of Agricultural and Food Chemistry, 2009. 57(19): p. 9299-9304.

82.	Park K H, Nan Y H, Park Y, Kim J I, Park I S, Hahm K S, and Shin S Y, Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. Biochim Biophys Acta, 2009. 1788(5): p. 1193-203.

2010년

83.	Yoon M Y, Gedi V, Kim J, Park Y, Kim D E, Park E H, and Choi J D, Structural and functional evaluation of three well-conserved serine residues in tobacco acetohydroxyacid synthase. Biochimie, 2010. 92(1): p. 65-70.

84.	Park Y, Park S, Kim J, Park J, Seo C, Nah J, and Hahm K, In vitro efficacy of a synthetic all-D antimicrobial peptide against clinically isolated drug-resistant strains. International Journal of Antimicrobial Agents, 2010. 35(2): p. 208-209.

85.	Apetrei A, Asandei A, Park Y, Hahm K S, Winterhalter M, and Luchian T, Unimolecular study of the interaction between the outer membrane protein OmpF from E. coli and an analogue of the HP (2–20) antimicrobial peptide. Journal of bioenergetics and biomembranes, 2010. 42(2): p. 173-180.

86.	Lee T H, Hall K N, Swann M J, Popplewell J F, Unabia S, Park Y, Hahm K S, and Aguilar M I, The membrane insertion of helical antimicrobial peptides from the N-terminus of Helicobacter pylori ribosomal protein L1. Biochimica et Biophysica Acta (BBA) - Biomembranes, 2010. 1798(3): p. 544-557.

87.	Hwang I, Kim S Y, Kim C S, Park Y, Tripathi G R, Kim S K, and Cheong H, Over-expression of the IGI1 leading to altered shoot-branching development related to MAX pathway in Arabidopsis. Plant molecular biology, 2010. 73(6): p. 629-641.

88.	Lee C, Park J, Hwang I, Park Y, and Cheong H, Expression of G-Ry derived from the potato (Solanum tuberosum L.) increases PVYO resistance. Journal of agricultural and food chemistry, 2010. 58(12): p. 7245-7251.

89.	Jeong N, Kim J Y, Park S C, Lee J K, Gopal R, Yoo S, Son B K, Hahm J S, Park Y, and Hahm K S, Antibiotic and synergistic effect of Leu–Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis. Biochemical and biophysical research communications, 2010. 399(4): p. 581-586.

90.	Chien P N, Moon J Y, Cho J H, Lee S J, Park J S, Kim D E, Park Y, and Yoon M Y, Characterization of acetohydroxyacid synthase I from Escherichia coli K-12 and identification of its inhibitors. Bioscience, biotechnology, and biochemistry, 2010. 74(11): p. 2281-2286.

2011년

91.	Kim J Y, Park S C, Yoon M Y, Hahm K S, and Park Y, C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria. Amino acids, 2011. 40(1): p. 183-195.

92.	Park S C, Kim J Y, Jeong C, Yoo S, Hahm K S, and Park Y, A plausible mode of action of pseudin-2, an antimicrobial peptide from Pseudis paradoxa. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2011. 1808(1): p. 171-182.

93.	Asandei A, Apetrei A, Park Y, Hahm K S, and Luchian T, Investigation of single-molecule kinetics mediated by weak hydrogen bonds within a biological nanopore. Langmuir, 2011. 27(1): p. 19-24.

94.	Park S C, Kim J Y, Lee J K, Yoo S, Kim H, Seo C H, Nah J W, Hahm K S, and Park Y, Synthetic diastereomeric‐antimicrobial peptide: Antibacterial activity against multiple drug resistant clinical isolates. Peptide Science, 2011. 96(2): p. 130-136.

95.	Hirst D J, Lee T H, Swann M J, Unabia S, Park Y, Hahm K S, and Aguilar M I, Effect of acyl chain structure and bilayer phase state on binding and penetration of a supported lipid bilayer by HPA3. European Biophysics Journal, 2011. 40(4): p. 503-514.

96.	Gopal R, Kim Y J, Seo C H, Hahm K S, and Park Y, Reversed sequence enhances antimicrobial activity of a synthetic peptide. Journal of Peptide Science, 2011. 17(5): p. 329-334.

97.	Yoo S, Kim J Y, Park S C, Choi D Y, Seo C H, Hahm K S, and Park Y, Effect of acidic pH on antibacterial action of peptide isolated from Korean pen shell (Atrina pectinata). Journal of Peptide Science, 2011. 17(5): p. 353-357.

98.	De Zotti M, Biondi B, Peggion C, Park Y, Hahm K S, Formaggio F, and Toniolo C, Synthesis, preferred conformation, protease stability, and membrane activity of heptaibin, a medium‐length peptaibiotic. Journal of Peptide Science, 2011. 17(8): p. 585-594.

99.	Ryu S, Choi S Y, Acharya S, Chun Y J, Gurley C, Park Y, Armstrong C A, Song P I, and Kim B J, Antimicrobial and anti-inflammatory effects of cecropin A (1-8)–Magainin2 (1-12) hybrid peptide analog P5 against Malassezia furfur infection in human keratinocytes. Journal of investigative dermatology, 2011. 131(8): p. 1677-1683.

100.	Park S C, Park Y, and Hahm K S, The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci, 2011. 12(9): p. 5971-92.

101.	Park S C, Lee J K, Kim S W, and Park Y, Selective algicidal action of peptides against harmful algal bloom species. PLoS One, 2011. 6(10): p. e26733.

2012년

102.	De Zotti M, Biondi B, Peggion C, Formaggio F, Park Y, Hahm K S, and Toniolo C, Trichogin GA IV: a versatile template for the synthesis of novel peptaibiotics. Org Biomol Chem, 2012. 10(6): p. 1285-99.

103.	Gopal R, Park J S, Seo C H, and Park Y, Applications of circular dichroism for structural analysis of gelatin and antimicrobial peptides. Int J Mol Sci, 2012. 13(3): p. 3229-44.

104.	Lee J K, Gopal R, Seo C H, Cheong H, and Park Y, Isolation and purification of a novel deca-antifungal peptide from potato (Solanum tuberosum L. cv. Jopung) against Candida albicans. Int J Mol Sci, 2012. 13(4): p. 4021-32.

105.	Park Y and Hahm K S, Novel short AMP: design and activity study. Protein Pept Lett, 2012. 19(6): p. 652-6.

106.	De Zotti M, Biondi B, Park Y, Hahm K S, Crisma M, Toniolo C, and Formaggio F, Antimicrobial lipopeptaibol trichogin GA IV: role of the three Aib residues on conformation and bioactivity. Amino Acids, 2012. 43(4): p. 1761-77.

107.	Park S C, Kim J Y, Lee J K, Hahm K S, and Park Y, Antibacterial action of new antibacterial peptides, Nod1 and Nod2, isolated from Nordotis discus discus. J Agric Food Chem, 2012. 60(27): p. 6875-81.

108.	Kim J Y, Park S C, Lee J K, Choi S J, Hahm K S, and Park Y, Novel antibacterial activity of β(2)-microglobulin in human amniotic fluid. PLoS One, 2012. 7(11): p. e47642.

109.	Schiopu I, Mereuta L, Apetrei A, Park Y, Hahm K S, and Luchian T, The role of tryptophan spatial arrangement for antimicrobial-derived, membrane-active peptides adsorption and activity. Mol Biosyst, 2012. 8(11): p. 2860-3.

110.	Gopal R, Na H, Seo C H, and Park Y, Antifungal activity of (KW)n or (RW)n peptide against Fusarium solani and Fusarium oxysporum. Int J Mol Sci, 2012. 13(11): p. 15042-53.

111.	Mereuta L, Schiopu I, Asandei A, Park Y, Hahm K S, and Luchian T, Protein nanopore-based, single-molecule exploration of copper binding to an antimicrobial-derived, histidine-containing chimera peptide. Langmuir, 2012. 28(49): p. 17079-91.

112.	Bobone S, Roversi D, Giordano L, De Zotti M, Formaggio F, Toniolo C, Park Y, and Stella L, The lipid dependence of antimicrobial peptide activity is an unreliable experimental test for different pore models. Biochemistry, 2012. 51(51): p. 10124-6.

2013년

113.	Gopal R, Seo C H, Song P I, and Park Y, Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Amino Acids, 2013. 44(2): p. 645-60.

114.	Lee J K, Park S C, Hahm K S, and Park Y, Antimicrobial HPA3NT3 peptide analogs: placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action. Biochim Biophys Acta, 2013. 1828(2): p. 443-54.

115.	Gopal R, Lee J K, Lee J H, Kim Y G, Oh G C, Seo C H, and Park Y, Effect of repetitive lysine-tryptophan motifs on the eukaryotic membrane. Int J Mol Sci, 2013. 14(1): p. 2190-202.

116.	Kim J Y, Gopal R, Kim S Y, Seo C H, Lee H B, Cheong H, and Park Y, PG-2, a Potent AMP against Pathogenic Microbial Strains, from Potato (Solanum tuberosum L cv. Gogu Valley) Tubers Not Cytotoxic against Human Cells. Int J Mol Sci, 2013. 14(2): p. 4349-60.

117.	Gopal R, Lee J H, Kim Y G, Kim M S, Seo C H, and Park Y, Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus. Mar Drugs, 2013. 11(6): p. 1836-52.

118.	Lee J K, Gopal R, Park S C, Ko H S, Kim Y, Hahm K S, and Park Y, A proline-hinge alters the characteristics of the amphipathic α-helical AMPs. PLoS One, 2013. 8(7): p. e67597.

119.	Bobone S, Bocchinfuso G, Park Y, Palleschi A, Hahm K S, and Stella L, The importance of being kinked: role of Pro residues in the selectivity of the helical antimicrobial peptide P5. J Pept Sci, 2013. 19(12): p. 758-69.

2014년

120.	Lee J K, Park S C, Hahm K S, and Park Y, A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice. Biomaterials, 2014. 35(3): p. 1025-39.

121.	Gopal R, Kim Y G, Lee J H, Lee S K, Chae J D, Son B K, Seo C H, and Park Y, Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother, 2014. 58(3): p. 1622-9.

122.	Mereuta L, Roy M, Asandei A, Lee J K, Park Y, Andricioaei I, and Luchian T, Slowing down single-molecule trafficking through a protein nanopore reveals intermediates for peptide translocation. Sci Rep, 2014. 4: p. 3885.

123.	Gopal R, Seo C H, and Park Y, The role of biophysical parameters in the antilipopolysaccharide activities of antimicrobial peptides from marine fish. Mar Drugs, 2014. 12(3): p. 1471-94.

124.	Ryu S, Song P I, Seo C H, Cheong H, and Park Y, Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides. Int J Mol Sci, 2014. 15(5): p. 8753-72.

125.	Mereuta L, Asandei A, Seo C H, Park Y, and Luchian T, Quantitative understanding of pH- and salt-mediated conformational folding of histidine-containing, β-hairpin-like peptides, through single-molecule probing with protein nanopores. ACS Appl Mater Interfaces, 2014. 6(15): p. 13242-56.

126.	Roversi D, Luca V, Aureli S, Park Y, Mangoni M L, and Stella L, How many antimicrobial peptide molecules kill a bacterium? The case of PMAP-23. ACS Chem Biol, 2014. 9(9): p. 2003-7.

127.	Gopal R, Jeong E, Seo C H, and Park Y, Role of antimicrobial peptides expressed by host cells upon infection by Helicobacter pylori. Protein Pept Lett, 2014. 21(10): p. 1057-64.

2015년

128.	Kang H K, Seo C H, and Park Y, Marine peptides and their anti-infective activities. Mar Drugs, 2015. 13(1): p. 618-54.

129.	Kang H K, Seo C H, and Park Y, The effects of marine carbohydrates and glycosylated compounds on human health. Int J Mol Sci, 2015. 16(3): p. 6018-56.

130.	Kang H-K and Park Y, Glycopeptide antibiotics: structure and mechanisms of action. Journal of Bacteriology and Virology, 2015. 45(2): p. 67-78.

131.	Asandei A, Chinappi M, Lee J K, Ho Seo C, Mereuta L, Park Y, and Luchian T, Placement of oppositely charged aminoacids at a polypeptide termini determines the voltage-controlled braking of polymer transport through nanometer-scale pores. Sci Rep, 2015. 5: p. 10419.

132.	Ryu S, Han H M, Song P I, Armstrong C A, and Park Y, Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice. PLoS One, 2015. 10(7): p. e0132619.

133.	Asandei A, Chinappi M, Kang H K, Seo C H, Mereuta L, Park Y, and Luchian T, Acidity-Mediated, Electrostatic Tuning of Asymmetrically Charged Peptides Interactions with Protein Nanopores. ACS Appl Mater Interfaces, 2015. 7(30): p. 16706-14.

134.	Ryu S, Johnson A, Park Y, Kim B, Norris D, Armstrong C A, and Song P I, The Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human Keratinocytes. PLoS One, 2015. 10(8): p. e0136887.

135.	Lee J K, Seo C H, Luchian T, and Park Y, Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli. Antimicrob Agents Chemother, 2016. 60(1): p. 495-506.

136.	Lee J K, Luchian T, and Park Y, Effect of Regular Exercise on Inflammation Induced by Drug-resistant Staphylococcus aureus 3089 in ICR mice. Sci Rep, 2015. 5: p. 16364.

137.	Kim Y G, Kang H K, Kwon K D, Seo C H, Lee H B, and Park Y, Antagonistic Activities of Novel Peptides from Bacillus amyloliquefaciens PT14 against Fusarium solani and Fusarium oxysporum. J Agric Food Chem, 2015. 63(48): p. 10380-7.

2016년

138.	Lee J K, Seo C H, Luchian T, and Park Y, Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli. Antimicrob Agents Chemother, 2016. 60(1): p. 495-506.

139.	Han H M, Gopal R, and Park Y, Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties. Amino Acids, 2016. 48(2): p. 505-22.

140.	Asandei A, Schiopu I, Chinappi M, Seo C H, Park Y, and Luchian T, Electroosmotic Trap Against the Electrophoretic Force Near a Protein Nanopore Reveals Peptide Dynamics During Capture and Translocation. ACS Appl Mater Interfaces, 2016. 8(20): p. 13166-79.

141.	Yeom J H, Lee B, Kim D, Lee J K, Kim S, Bae J, Park Y, and Lee K, Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium. Biomaterials, 2016. 104: p. 43-51.

142.	Apetrei A, Ciuca A, Lee J K, Seo C H, Park Y, and Luchian T, A Protein Nanopore-Based Approach for Bacteria Sensing. Nanoscale Res Lett, 2016. 11(1): p. 501.

2017년

143.	Kang H K, Kim C, Seo C H, and Park Y, The therapeutic applications of antimicrobial peptides (AMPs): a patent review. J Microbiol, 2017. 55(1): p. 1-12.

144.	Savini F, Luca V, Bocedi A, Massoud R, Park Y, Mangoni M L, and Stella L, Cell-Density Dependence of Host-Defense Peptide Activity and Selectivity in the Presence of Host Cells. ACS Chem Biol, 2017. 12(1): p. 52-56.

145.	Asandei A, Ciuca A, Apetrei A, Schiopu I, Mereuta L, Seo C H, Park Y, and Luchian T, Nanoscale Investigation of Generation 1 PAMAM Dendrimers Interaction with a Protein Nanopore. Sci Rep, 2017. 7(1): p. 6167.

146.	Asandei A, Rossini A E, Chinappi M, Park Y, and Luchian T, Protein Nanopore-Based Discrimination between Selected Neutral Amino Acids from Polypeptides. Langmuir, 2017. 33(50): p. 14451-14459.

147.	Han H M, Ko S, Cheong M J, Bang J K, Seo C H, Luchian T, and Park Y, Myxinidin2 and myxinidin3 suppress inflammatory responses through STAT3 and MAPKs to promote wound healing. Oncotarget, 2017. 8(50): p. 87582-87597.

148.	Jeon D, Jeong M C, Jacob B, Bang J K, Kim E H, Cheong C, Jung I D, Park Y, and Kim Y, Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity. Sci Rep, 2017. 7(1): p. 1455.

149.	Ko S J, Kim M K, Bang J K, Seo C H, Luchian T, and Park Y, Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria. Sci Rep, 2017. 7(1): p. 16580.

150.	Lee B, Park J, Ryu M, Kim S, Joo M, Yeom J H, Kim S, Park Y, Lee K, and Bae J, Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus. Sci Rep, 2017. 7(1): p. 13572.

2018년

151.	Kim M K, Kang H K, Ko S J, Hong M J, Bang J K, Seo C H, and Park Y, Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa. Sci Rep, 2018. 8(1): p. 1763.

152.	Cho E, Lee J K, Park E, Seo C H, Luchian T, and Park Y, Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer. Oncotarget, 2018. 9(8): p. 7902-7917.

153.	Lee J K, Luchian T, and Park Y, New antimicrobial peptide kills drug-resistant pathogens without detectable resistance. Oncotarget, 2018. 9(21): p. 15616-15634.

154.	Kang H K, Choi M C, Seo C H, and Park Y, Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides. Int J Mol Sci, 2018. 19(3).

155.	Lee J K and Park Y, Anti-endotoxin mechanism of the KW4 peptide in inflammation in RAW 264.7 cells induced by LTA and drug-resistant Staphylococcus aureus 1630. Amino Acids, 2018. 50(3-4): p. 363-372.

156.	Ryu S, Ahn Y J, Yoon C, Chang J H, Park Y, Kim T H, Howland A R, Armstrong C A, Song P I, and Moon A R, The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells. BMC Cancer, 2018. 18(1): p. 432.

157.	Asandei A, Schiopu I, Ciobanasu C, Park Y, and Luchian T, If Squeezed, a Camel Passes Through the Eye of a Needle: Voltage-Mediated Stretching of Dendrimers Facilitates Passage Through a Nanopore. J Membr Biol, 2018. 251(3): p. 405-417.

158.	Ciuca A, Asandei A, Schiopu I, Apetrei A, Mereuta L, Seo C H, Park Y, and Luchian T, Single-Molecule, Real-Time Dissecting of Peptide Nucleic Acid-DNA Duplexes with a Protein Nanopore Tweezer. Anal Chem, 2018. 90(12): p. 7682-7690.

159.	Park J, Kang H K, Choi M C, Chae J D, Son B K, Chong Y P, Seo C H, and Park Y, Antibacterial activity and mechanism of action of analogues derived from the antimicrobial peptide mBjAMP1 isolated from Branchiostoma japonicum. J Antimicrob Chemother, 2018. 73(8): p. 2054-2063.

160.	Asandei A, Dragomir I S, Di Muccio G, Chinappi M, Park Y, and Luchian T, Single-Molecule Dynamics and Discrimination between Hydrophilic and Hydrophobic Amino Acids in Peptides, through Controllable, Stepwise Translocation across Nanopores. Polymers (Basel), 2018. 10(8).

161.	Choi M C, MaruYama T, Chun C H, and Park Y, Alleviation of Murine Osteoarthritis by Cartilage-Specific Deletion of IκBζ. Arthritis Rheumatol, 2018. 70(9): p. 1440-1449.

162.	Kim M K, Kang N, Ko S J, Park J, Park E, Shin D W, Kim S H, Lee S A, Lee J I, Lee S H, Ha E G, Jeon S H, and Park Y, Antibacterial and Antibiofilm Activity and Mode of Action of Magainin 2 against Drug-Resistant Acinetobacter baumannii. Int J Mol Sci, 2018. 19(10).

163.	Arayan L T, Kim H B, Bernardo Reyes A W, Xuan Huy N T, Hong I H, Lee K, Yeom J H, Park Y, and Kim S, The immunomodulatory effect of antimicrobial peptide HPA3P restricts Brucella abortus 544 infection in BALB/c mice. Vet Microbiol, 2018. 225: p. 17-24.

164.	Kang H K, Seo C H, Luchian T, and Park Y, Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection. Antimicrob Agents Chemother, 2018. 62(12).

2019년

165.	Luchian T, Park Y, Asandei A, Schiopu I, Mereuta L, and Apetrei A, Nanoscale Probing of Informational Polymers with Nanopores. Applications to Amyloidogenic Fragments, Peptides, and DNA-PNA Hybrids. Acc Chem Res, 2019. 52(1): p. 267-276.

166.	Ko S J, Kang N H, Kim M K, Park J, Park E, Park G H, Kang T W, Na D E, Park J B, Yi Y E, Jeon S H, and Park Y, Antibacterial and anti-biofilm activity, and mechanism of action of pleurocidin against drug resistant Staphylococcus aureus. Microb Pathog, 2019. 127: p. 70-78.

167.	Kang H K, Lee H H, Seo C H, and Park Y, Antimicrobial and Immunomodulatory Properties and Applications of Marine-Derived Proteins and Peptides. Mar Drugs, 2019. 17(6).

168.	Asandei A, Mereuta L, Park J, Seo C H, Park Y, and Luchian T, Nonfunctionalized PNAs as Beacons for Nucleic Acid Detection in a Nanopore System. ACS Sens, 2019. 4(6): p. 1502-1507.

169.	Mereuta L, Asandei A, Schiopu I, Park Y, and Luchian T, Nanopore-Assisted, Sequence-Specific Detection, and Single-Molecule Hybridization Analysis of Short, Single-Stranded DNAs. Anal Chem, 2019. 91(13): p. 8630-8637.

170.	Choi M C, Jo J, Park J, Kang H K, and Park Y, NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction. Cells, 2019. 8(7).

171.	Kwon J Y, Kim M K, Mereuta L, Seo C H, Luchian T, and Park Y, Mechanism of action of antimicrobial peptide P5 truncations against Pseudomonas aeruginosa and Staphylococcus aureus. AMB Express, 2019. 9(1): p. 122.

172.	Lee J K, Mereuta L, Luchian T, and Park Y, Antimicrobial peptide HPA3NT3-A2 effectively inhibits biofilm formation in mice infected with drug-resistant bacteria. Biomater Sci, 2019. 7(12): p. 5068-5083.

173.	Han S I, Kim S, Choi K Y, Lee C, Park Y, and Choi Y E, Control of a toxic cyanobacterial bloom species, Microcystis aeruginosa, using the peptide HPA3NT3-A2. Environ Sci Pollut Res Int, 2019. 26(31): p. 32255-32265.

174.	Moon A R, Park Y, Chang J H, and Lee S S, Inverse regulation of serum osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand levels in patients with leg lesional vascular calcification: An observational study. Medicine (Baltimore), 2019. 98(10): p. e14489.

2020년

175.	Ramamourthy G, Park J, Seo C, H J V, and Park Y, Antifungal and Antibiofilm Activities and the Mechanism of Action of Repeating Lysine-Tryptophan Peptides against Candida albicans. Microorganisms, 2020. 8(5).

176.	Ko S J, Park E, Asandei A, Choi J Y, Lee S C, Seo C H, Luchian T, and Park Y, Bee venom-derived antimicrobial peptide melectin has broad-spectrum potency, cell selectivity, and salt-resistant properties. Sci Rep, 2020. 10(1): p. 10145.

178.	Mereuta L, Asandei A, Dragomir I S, Bucataru I C, Park J, Seo C H, Park Y, and Luchian T, Sequence-specific detection of single-stranded DNA with a gold nanoparticle-protein nanopore approach. Sci Rep, 2020. 10(1): p. 11323.

179.	Lee J K and Park Y, All d-Lysine Analogues of the Antimicrobial Peptide HPA3NT3-A2 Increased Serum Stability and without Drug Resistance. Int J Mol Sci, 2020. 21(16).

180.	Mereuta L, Asandei A, Dragomir I S, Bucataru I C, Park J, Seo C H, Park Y, and Luchian T, Author Correction: Sequence-specific detection of single-stranded DNA with a gold nanoparticle-protein nanopore approach. Sci Rep, 2020. 10(1): p. 16141.

181.	Park J, Oh J H, Kang H K, Choi M C, Seo C H, and Park Y, Scorpion-Venom-Derived Antimicrobial Peptide Css54 Exerts Potent Antimicrobial Activity by Disrupting Bacterial Membrane of Zoonotic Bacteria. Antibiotics (Basel), 2020. 9(11).

182.	Asandei A, Mereuta L, Schiopu I, Park J, Seo C H, Park Y, and Luchian T, Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit. ACS Appl Mater Interfaces, 2020. 12(50): p. 55649-55658.

2021년

183.	Choi M C, Jo J, Lee M, Park J, and Park Y, Intra-Articular Administration of Cramp into Mouse Knee Joint Exacerbates Experimental Osteoarthritis Progression. Int J Mol Sci, 2021. 22(7).

• PATENT

Process for production a human interleukin-2 protein in a potato and method of promoting the growth of a potato using interleukin-2 transformants. OP857-GE-USA. January17,1999.(USA)

Human interleukin-2 protein production method in Potato. Patent no: 0278229, 2000. (Korea)

헬리코박터 파일로리균의 리보좀 L1 유래의 새로운 항생 펩타이드 및 그의 용도, 대한민국 특허등록 제 0459808호. 2004년

바실러스 속 균주 유래의 폴리 감마 글루탐산 합성유전자를 이용한 펩타이드 항생물질 P5와 Anal3의 표면 발현 방법 및 그의 용도. 출원번호: 10-2002-0063378. (2002. 10. 17). 특허등록: 제 0525759 호. (2005년 10월 26일)

항균 및 항진균 활성을 가지는 항생 펩타이드. 출원번호: 제2004-34168호, 출원일: 2004년 5월 14일, 특허등록: 제 10-0571659호. (2006년 4월 11일)

헬리코박터 파일로리균의 리보좀 단백질 L1 유래의 새로운 항생제용 접합 펩타이드 및 그의 용도. 2004. 5. 11 특허 등록. 2004-0438414호는 하

CA-MA 펩타이드의 아미노산 중 하나 또는 그 이상을 치환하여 + 전극과 소수성 영역이 증가된 신규한 펩타이드 및 그를 포함하는 약학적 조성물. 2004년 3월 26일. 2004-0438416. 특허등록

Surface expression method of peptides P5 and Anal 3 using the gene encoding poly-gamma-glutamate synthetase. 2004년 2월 27일 (US 10/789, 164). 미국 특허 출원

Novel peptide with increased +charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof. 2004년 10월 5일 제 6,800,727호 (미국 특허 등록)

아스퍼질러스 니듈란스(Aspergillusnidulans)로부터 분리한 신규 펩타이드 및 이를 유효성분으로 함유하는 약학적 조성물. 2004년 11월 2일. 10-2004-0088456. 특허출원. 2006년 9월 12일. 특허등록. 제 10-0625875호

고구밸리 품종의 감자로부터 유래된 펩타이드 및 상기 펩타이드의 기능성 소재로의 용도. 2004년 11월 16일. 제 2004-93553호. 특허등록: 2006년 11월 29일. 특허 제 10-0654231 호

골든밸리 품종의 감자로부터 분리된 열안정성 펩타이드 및 상기 펩타이드를 유효성분으로 함유하는 기능성 소재로의 용도. 2004년 11월 23일. 제 2004-96363호. 특허등록: 2006년 11월 29일. 특허 제 10-0654232호

아스퍼질러스 니듈런스로부터 분리한 펩타이드인 유비딘 및 이를 유효성분으로 함유하는 항생제. 2004년 11월 17일. 제2004-93848호 출원. 2006년 8월 7일 등록: 제 10-0612375호

Novel peptide isolated from Aspergillus nidulans and pharmaceutical composition containing the same, 출원번호: PCT/KR2005/003120. 2005년 9월 21일

Ubidine, peptide isolated from Aspergillus and antibiotics containing the same, 출원번호: PCT/KR2005/003121. 2005년 9월 21일

항생 펩타이드 및 이를 유효성분으로 함유하는 항생제. 출원번호: 제2003-54880호, 출원일: 2003년 8월 8일, 등록일 2006년 3월 3일. 제 10-0559487호

신균주인 바실러스 서브틸리스 에스원, 이로부터 정제한 신규 펩타이드 및 이의 용도(Novel bacterium Bacillus subtilis S1, novel peptides from it and use thereof). 출원번호: 제2006-0114038호, 출원일: 2006년 11월 17일. 등록일: 2012년 3월 22일, 등록번호: 제 1131563.

헬리코박터 파일로리균의 리보좀 단백질 L1 유래의 새로운 접힘 구조를 갖는 항생 펩타이드 및 조성물(Novel synthetic antimicrobial hinge peptide derived from Ribosomal Protein L1 of Helicobacter pylori and composition therefrom). 특허출원 제 2007-0064230호, 2007년 6월 28일. 특허 등록 제 0935029호. 등록일: 2009년 12월 23일.

새로운 세포투과성 펩타이드 및 이를 이용한 생물학적 활성 물질의 전달 방법 특허출원 제 2007-81208호, 2007년 8월 13일. 특허 등록 제 0935030호. 등록일: 2009년 12월 23일.

헬리코박터 파일로리균의 리보좀 단백질 L1 유래의 유사체 펩타이드로부터 풀림구조를 절단한 양이온 증가 항생 펩타이드 및 조성물. 특허출원 10-2007-0088127호, 2007년 8월 31일. 특허등록: 제 0935031호. 등록일: 2009년 12월 23일

저분자 수용성 키토산 또는 이의 유도체를 유효성분으로 함유하는 항생제, 특허출원 제 2007-101068호, 2007년 10월 8일

병원균의 감염에 의해 특이적으로 발현되는 골든밸리 유래의 단백질 Ry, 제 10-2007-0125245호, 2007. 12월 5일. 등록번호: 제 10-0971403호, 등록일: 2010년 7월 14일.

신품종 감자에서 추출하여 항균 펩타이드를 유효성분으로 하는 기능성 단백질의 사료적 응용.

Surface expression method of peptides P5 and Anal 3 using the gene encoding poly-gamma-glutamate synthetase. 2004년 2월 27일 (US 10/789, 164). 미국특허 출원. 2007년 8월 14일 미국특허 등록

트립토판 풍부 모델형 항균 펩타이드와 비자연계 아미노산 치환 아날로그 및 그의 용도, 대한민국 특허출원 제 10-2007-0094612호, 2007, 등록: 제 10-0883815호, 2009년 2월 9일

신품종 고구밸리 감자를 이용한 암 예방을 위한 건강기능식품. 2008년 4월 28일. 출원번호: 10-2008-0039284. 등록번호: 제 0883566호, 등록일자: 2009년 2월 6일

고구밸리 감자에서 추출된 단백질 추출물 또는 펩타이드를 함유하는 항암용 약학 조성물. 2008년 4월 28일. 출원번호: 10-2008-0039285. 등록: 제 10-0963094호. 2010년 6월 1일

아토피성 피부염 예방 또는 치료용 조성물, 출원번호: 제 2008-105516, 출원일: 2008년 10월 27일. 등록번호: 제 10-1070805호. 등록일: 2011년 9월 29일

적조유발 생물에 항조류 활성을 가지는 적조 방제용 펩타이드, 그의 용도 및 이의 제조 방법. 출원번호 2009-13448호, 출원일: 2009년 2월 18일

적조유발 조류에 항적조 활성을 갖는 수용성 유리 아민 키토산, 이를 유효성분으로 함유하는 항적조제 및 이를 이용한 적조 제거방법. 특허출원 제 2009-0081087호, 출원일: 2009년 8월 31일

호박 껍질 유래의 신규한 항진균 펩타이드 및 그의 용도. 출원번호: 10-2010-0025215, 출원일: 2010.03.22. 등록

적조유발 생물에 항조류 활성을 가지는 적조 방제용 펩타이드, 그의 용도 및 이의 제조 방법. PCT/KR2010/005473, 출원일자: 2010년 8월 18일

항적조 활성을 가지는 HPA3NT3 펩타이드 및 그의 용도. 제 2010-0080018호, 출원일: 2010년 8월 18일

항적조 활성을 가지는 P5 펩타이드 및 그의 용도. 제 2010-0080012호, 출원일: 2010년 8월 18일

항생제 대체용 A3 펩타이드를 함유하는 사료첨가제 및 그의 제조 방법. 제 2011-0057908호, 출원일 2011년 6월 15일

항생제 대체용 P5 펩타이드를 함유하는 사료첨가제 및 그의 제조 방법. 제 2011-0057907호, 출원일 2011년 6월 15일

키조개로부터 유래된 신규한 항균펩타이드 및 이의 용도. 제 2011-0053429호, 출원일 2011년 6월 2일

항적조 활성을 가진 펩타이드 및 그의 용도. 제 PCT/KR2011/006001호, 출원일: 2011년 8월 16일

적조유발 생물에 항조류 활성을 가지는 적조 방제용 펩타이드, 그의 용도 및 이의 제조방법. 대한민국 등록번호(10-1062793). 등록일: 2011.08.31

라이신 및 트립토판 잔기가 4번 반복된 신규한 항균 및 항진균펩타이드 및 이의 용도. 출원번호: 제 2011-0147577호. 출원일: 2011년 12월 30일

감자로부터 분리한 신규한 항진균 펩타이드 및 이의 용도. 출원번호: 제 2012-0000952호. 출원일: 2012년 1월 4일

바실러스 아밀로리쿼페이션스 EML-CAP3, 이를 함유하는 식물병 방제용 조성물 및 식물병 방제 방법. 출원번호: 10-2012-0013124. 출원일: 2012.02.09.

Ry 유전자로 형질 전환된 PVY에 내성이 있는 감자 식물체 및 이의 제조 방법. 출원번호: 10-2009-0059546. 출원일: 2009년 7월 1일. 등록번호: 제 10-1118561호. 등록일: 2012년 2월 14일

HPA3NT3 항적조 펩타이드가 탑재된 CsNIV 캡시드 및 이의 용도. 출원번호: 제 2012-0015863호. 출원일: 2012년 2월 16일

저분자 수용성 키토산 또는 이의 유도체를 유효성분으로 함유하는 항생제. 출원번호: 제 2009-0091071호. 출원일: 2009년 9월 25일. 등록번호: 제10-1062799호. 등록일: 2011년 8월 31일

헬리코박터 파일로리균의 리보좀 단백질 L1 유래의 새로운 항생 펩타이드 및 그의 용도(Novel antibiotic peptide derived from ribosomal protein L1 of Helicobacter pylori and use thereof). 출원번호: 10-2008-0117335. 출원일자: 2008. 11. 25. 미국, 캐나다, 일본, 대한민국

- 캐나다 출원번호 : PCT/KR2008/006938, 출원일자 (2010년 7월 2일)

- 미국
- 일본 PCT/2010-544878, 출원 일자 (2010년 12월 2일), 등록번호 특허 제 5202649호 2013년

2월 22일.

- 대한민국 등록번호: 제 10-1077180호. 등록일: 2011년 10월 20일

인간의 양수로부터 분리 정제된 항균 활성 단백질 및 이의 용도. 출원번호: 제 2012-0021908호. 출원일: 2012년 3월 2일

전복으로부터 분리된 신규한 항생펩타이드 및 이의용도. 출원번호: 제 2012-0022744호. 출원일: 2012년 3월 6일.

미더덕 유래 항균 펩타이드의 신규한 유사체 및 이의 용도. 출원번호: 제 2012-0026472호. 출원일: 2012년 3월 15일

프로피오니박테리움 아크네스에 작용하는 신규한 항생 펩타이드 및 이의 용도. 출원번호: 제 2012-0030218호. 출원일: 2012년 03월 23일

바실러스 아밀로리쿼파시엔스 EML-CAP3으로부터 분리된 신규한 항균 및 항진균 펩타이드 및 이의 용도. 출원번호: 제 2012-0077156호. 출원일: 2012년 07월 16일

고구밸리 품종의 감자로부터 유래된 신규한 항진균 펩타이드 PG-2 및 이의 용도. 출원번호: PCT/KR2012/008424. 출원일자: 2012년 10월 16일

헬리코박터 파일로리균의 리보좀 단백질 L1으로부터 유래된 신규한 항생 펩타이드 및 이의 용도. 출원번호: 2013-0001074호. 출원일자: 2013년 1월 4일

헬리코박터 파일로리균의 리보좀 단백질 L1으로부터 유래된 신규한 항생 펩타이드 및 이의 용도. 대한민국 특허등록 제 10-1583025호. (2015년 12월 30일)

CM-MA 펩타이드로부터 유래된 유사체 펩타이드 CMA3 및 이의 용도. 대한민국 특허등록 제 10-1595440호. (2016년 2월 12일)

클라바스피린 펩타이드 유사체를 유효성분으로 함유하는 항염증용 조성물(Anti-inflammatory composition comprising clavaspirin peptide analogue as effective component) 대한민국 특허등록 제 10-1713143호. 2016년 9월 10일

헬리코박터 파일로리균의 리보좀 단백질 L1 유래의 새로운 항생펩타이드 및 그의 용도. 2016년 5월 24일 (2,711,462). 캐나다특허 등록

헬리코박터 파일로리균의 리보좀 단백질 L1으로부터 유래된 신규한 항생 펩타이드 및 이의 용도. 2016년 10월 11일 (US 9,463,214 B2). 미국특허 등록

바실러스 아미로리쿼파시엔스 EML-CAP-03으로부터 분리된 신규한 항진균 펩타이드 BA-1 및 이의 용도. 특허등록 제 10-1716765호. 2017년 3월 9일

마이시니딘 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도(Novel antimicrobial peptide derived from myxinidin peptide and uses thereof) 특허등록 제 10-1734064호. 2017년 5월 2일

CM-MA 펩타이드로부터 유래된 유사체 펩타이드 CMA3 및 이의 용도. 2018년 1월 9일 (US 9,862,749 B2). 미국특허 등록

α-헤모라이신 단백질과 항미생물 펩티드를 함유하는 수계 시료 내의 박테리아 검출용 센서 및 상기 센서를 이용한 수계 시료 내의 박테리아 검출 방법(Sensor for detecting bacteria in aqueous sample containing α-hemolysin and antimicrobial peptide and method for detecting bacteria in aqueous sample using the same). 특허등록 제 10-1909446호. 2018년 10월 12일

항균용 나노 구조체 및 이의 용도(Antimicrobial nano-complex, and uses thereof). 특허등록 제 10-1966505호. 2019년 4월 1일

홍어 껍질 유래의 신규한 항균 펩타이드 및 이의 용도(Novel antimicrobial peptide from Skate skin and uses thereof). 특허등록 제 10-1976573호. 2019년 5월 2일

LL37 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도(Novel antimicrobial peptide derived from LL37 peptide and uses thereof). 특허등록 제 10-1980897호. 2019년 5월 15일

라이신 및 트립토판 잔기가 4번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도. 2019년 5월 28일 (US 10,301,354 B2) 미국특허 등록.

Hp1404 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도(Novel antimicrobial peptide derived from Hp1404 peptide and uses thereof). 특허등록 제 10-1998106호. 2019년 7월 3일

Pseudin-2 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도. 출원번호: 제 10-2019-003342, 출원일: 2019년 3월 25일, 특허등록: 제 10-2158036호. 2020년 9월 15일

Novel antimicrobial peptide derived from myxinidin peptide and uses thereof. 미국 출원번호: US15/757,793. 출원일: 2018년 3월 6일. 미국특허 등록 2020년 11월 4일

Novel antimicrobial peptide derived from Hp1404 peptide and uses thereof. 미국 출원번호: US16/648,060. 출원일: 2020년 3월 17일

Novel antimicrobial peptide from skate skin and uses thereof. 출원번호: PCT/KR2018/010459. 출원일: 2020년 3월 17일

Novel antimicrobial peptide derived from LL37 peptide and uses thereof. 미국 출원번호: US16/978,387. 출원일: 2020년 9월 4일